Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 473-478

  Qin, Weiping ^a,b   Pan, Jiangping ^a   Wu, Yong ^a   Bauman, William A ^a,b   Cardozo, Christopher ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

FOXO1; Glucocorticoid; Muscle atrophy; PGC 1 ; Protein catabolism; Protein synthesis; Testosterone

Indexed keywords

ADENYLATE KINASE; DEXAMETHASONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TESTOSTERONE; TRANSCRIPTION FACTOR FKHR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; HORMONAL REGULATION; MUSCLE ATROPHY; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOIDS; MUSCULAR ATROPHY; NERVE TISSUE PROTEINS; RATS; RNA-BINDING PROTEINS; TESTOSTERONE; TRANSCRIPTION FACTORS;

ANIMALIA; RATTUS;

EID: 78650176538     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.061     Document Type: Article

References (35)

1. Kayali A.G., Young V.R., Goodman M.N. Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am. J. Physiol. 1987, 252:E621-E626.
2. Millward D.J., Garlick P.J., Nnanyelugo D.O., Waterlow J.C. The relative importance of muscle protein synthesis and breakdown in the regulation of muscle mass. Biochem. J. 1976, 156:185-188.
3. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
4. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
5. Waddell D.S., Baehr L.M., van den Brandt J., Johnsen S.A., Reichardt H.M., Furlow J.D., Bodine S.C. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E785-E797.
6. Lecker S.H., Jagoe R.T., Gilbert A., Gomes M., Baracos V., Bailey J., Price S.R., Mitch W.E., Goldberg A.L. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004, 18:39-51.
7. Clarke B.A., Drujan D., Willis M.S., Murphy L.O., Corpina R.A., Burova E., Rakhilin S.V., Stitt T.N., Patterson C., Latres E., Glass D.J. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 2007, 6:376-385.
8. Shah O.J., Kimball S.R., Jefferson L.S. Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E76-E82.
9. Wang H., Kubica N., Ellisen L.W., Jefferson L.S., Kimball S.R. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J. Biol. Chem. 2006, 281:39128-39134.
10. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 2005, 17:596-603.
11. Sofer A., Lei K., Johannessen C.M., Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 2005, 25:5834-5845.
12. Sacheck J.M., Hyatt J.P., Raffaello A., Jagoe R.T., Roy R.R., Edgerton V.R., Lecker S.H., Goldberg A.L. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 2007, 21:140-155.
13. Wu Y., Zhao W., Zhao J., Zhang Y., Qin W., Pan J., Bauman W.A., Blitzer R.D., Cardozo C. REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology 2009, 151:1050-1059.
14. Imae M., Fu Z., Yoshida A., Noguchi T., Kato H. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J. Mol. Endocrinol. 2003, 30:253-262.
15. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., Mochida K., Hata T., Matsuda J., Aburatani H., Nishino I., Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 2004, 279:41114-41123.
16. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., Gonzalez M., Yancopoulos G.D., Glass D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 2004, 14:395-403.
17. DeYoung M.P., Horak P., Sofer A., Sgroi D., Ellisen L.W. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev. 2008, 22:239-251.
18. Southgate R.J., Neill B., Prelovsek O., El-Osta A., Kamei Y., Miura S., Ezaki O., McLoughlin T.J., Zhang W., Unterman T.G., Febbraio M.A. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J. Biol. Chem. 2007, 282:21176-21186.
19. Zhao W., Qin W., Pan J., Wu Y., Bauman W.A., Cardozo C. Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor. Biochem. Biophys. Res. Commun. 2009, 378:668-672.
20. Sandri M., Lin J., Handschin C., Yang W., Arany Z.P., Lecker S.H., Goldberg A.L., Spiegelman B.M. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl. Acad. Sci. USA 2006, 103:16260-16265.
21. Wright D.C., Han D.H., Garcia-Roves P.M., Geiger P.C., Jones T.E., Holloszy J.O. Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression. J. Biol. Chem. 2007, 282:194-199.
22. Lee W.J., Kim M., Park H.S., Kim H.S., Jeon M.J., Oh K.S., Koh E.H., Won J.C., Kim M.S., Oh G.T., Yoon M., Lee K.U., Park J.Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem. Biophys. Res. Commun. 2006, 340:291-295.
23. Reid I.R., Wattie D.J., Evans M.C., Stapleton J.P. Testosterone therapy in glucocorticoid-treated men. Arch. Intern. Med. 1996, 156:1173-1177.
24. Crawford B.A., Liu P.Y., Kean M.T., Bleasel J.F., Handelsman D.J. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J. Clin. Endocrinol. Metab. 2003, 88:3167-3176.
25. Zhao W., Pan J., Zhao Z., Wu Y., Bauman W.A., Cardozo C.P. Testosterone protects against dexamethasone-induced muscle atrophy, protein degradation and MAFbx upregulation. J. Steroid Biochem. Mol. Biol. 2008, 110:125-129.
26. Zhao J., Zhang Y., Zhao W., Wu Y., Pan J., Bauman W.A., Cardozo C. Effects of nandrolone on denervation atrophy depend upon time after nerve transection. Muscle Nerve 2008, 37:42-49.
27. Zhao W., Pan J., Wang X., Wu Y., Bauman W.A., Cardozo C.P. Expression of the muscle arophy factor MAFbx is suppressed by testosterone. Endocrinology 2008, 149:5449-5460.
28. Haddad F., Roy R.R., Zhong H., Edgerton V.R., Baldwin K.M. Atrophy responses to muscle inactivity. II. Molecular markers of protein deficits. J. Appl. Physiol. 2003, 95:791-802.
29. Hyatt J.P., Roy R.R., Baldwin K.M., Edgerton V.R. Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonuclei. Am. J. Physiol. Cell. Physiol. 2003, 285:C1161-C1173.
30. Finck B.N., Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 2006, 116:615-622.
31. Sano M., Tokudome S., Shimizu N., Yoshikawa N., Ogawa C., Shirakawa K., Endo J., Katayama T., Yuasa S., Ieda M., Makino S., Hattori F., Tanaka H., Fukuda K. Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. J. Biol. Chem. 2007, 282:25970-25980.
32. Aoi W., Naito Y., Mizushima K., Takanami Y., Kawai Y., Ichikawa H., Yoshikawa T. The microRNA miR-696 regulates PGC-1{alpha} in mouse skeletal muscle in response to physical activity. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E799-E806.
33. Lasa M., Brook M., Saklatvala J., Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 2001, 21:771-780.
34. Brown D., Hikim A.P., Kovacheva E.L., Sinha-Hikim I. Mouse model of testosterone-induced muscle fiber hypertrophy: involvement of p38 mitogen-activated protein kinase-mediated Notch signaling. J. Endocrinol. 2009, 201:129-139.
35. Jones A., Hwang D.J., Narayanan R., Miller D.D., Dalton J.T. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 2010, 151:3706-3719.